Genetically modified bacillus subtilis strain and use as a live delivery and production system
US-2024390433-A1 · Nov 28, 2024 · US
US9528115B1 · US · B1
| Field | Value |
|---|---|
| Publication number | US-9528115-B1 |
| Application number | US-201414208543-A |
| Country | US |
| Kind code | B1 |
| Filing date | Mar 13, 2014 |
| Priority date | Mar 15, 2013 |
| Publication date | Dec 27, 2016 |
| Grant date | Dec 27, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In exemplary embodiments, the invention provides Pseudomonas fluorescens 2-79 strains having pyrrolnitrin biosynthetic genes for biocontrol of soilborne diseases.
Opening claim text (preview).
What is claimed is: 1. A recombinant Pseudomonas fluorescens 2-79 strain comprising a stably transformed pyrrolnitrin (Prn) biosynthetic operon from Pseudomonas fluorescens Pf-5, wherein said recombinant Pseudomonas fluorescens 2-79 strain produces pyrrolnitrin from said Prn biosynthetic operon and wherein said recombinant Pseudomonas fluorescens 2-79 strain is a member selected from the group consisting of the recombinant Pseudomonas fluorescens 2-79 strains deposited under Reference Nos: NRRL 67312 and NRRL 67313. 2. The recombinant Pseudomonas fluorescens 2-79 strain of claim 1 , wherein said recombinant Pseudomonas fluorescens 2-79 strain has antibiotic activity against Rhizoctonia solani, Rhizoctonia oryzae, Gaeumannomyces graminis var, tritici , or a combination thereof. 3. The recombinant Pseudomonas fluorescens 2-79 strain of claim 2 , wherein said recombinant Pseudomonas fluorescens strain has enhanced antibiotic activity against Gaeumannomyces graminis var, tritici as compared to a parental Pseudomonas fluorescens 2-79 strain. 4. The recombinant Pseudomonas fluorescens 2-79 strain of claim 1 , wherein said recombinant Pseudomonas fluorescens 2-79 strain controls take-all and Rhizocotonia root rot significantly better than a parental Pseudomonas fluorescens 2-79 strain. 5. The recombinant Pseudomonas fluorescens 2-79 strain of claim 1 , wherein said recombinant Pseudomonas fluorescens 2-79 strain is the strain deposited under Reference No. NRRL 67312. 6. The recombinant Pseudomonas fluorescens 2-79 of claim 1 , wherein said recombinant Pseudomonas fluorescens 2-79 strain is the strain deposited under Reference No. NRRL 67313.
Related publications grouped by family.
Answers are generated from the same data shown on this page.